BeOne Medicines Ltd. (ONC) has a consensus analyst rating of Buy, based on 13 analysts covering the stock. Of those, 12 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for ONC is $409.67, representing a +32.2% upside from the current price of $310. Price targets range from a low of $394.00 to a high of $425.00.
